Article Details

Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer

Retrieved on: 2019-01-03 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer. View article details on hiswai:

Excerpt

<div>... Deerfield Management, <b>U.S. Venture Partners</b>, Osage University Partners, Takeda Ventures and Euclidean Capital. See here for more on Ribon.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up